Which has the lower trailing P/E, ALNY or MTD?

MTD has the lower trailing P/E: ALNY trades at 68.08 and MTD at 32.51. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ALNY or MTD?

Over the past five years, ALNY grew revenue faster — ALNY at a 49.67% CAGR versus MTD at 4.77%.

Is ALNY or MTD more profitable?

MTD runs the higher net margin — ALNY at 13.46% versus MTD at 21.40%.

How have ALNY and MTD total returns compared?

Over the past 10 years, ALNY delivered 15.46% and MTD delivered 12.94% annualized total return. Past performance doesn't predict future results.

Alnylam Pharmaceuticals, Inc. (ALNY) vs Mettler-Toledo International Inc. (MTD)

A side-by-side comparison of Alnylam Pharmaceuticals, Inc. and Mettler-Toledo International Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 30, 2026. Differences are shown without an overall score or investment verdict.

ALNY

Alnylam Pharmaceuticals, Inc.

$27.75B

$207.86HealthcareDelayed quote: Jul 30, 2026, 11:10 AM EDT

MTD

Mettler-Toledo International Inc.

$27.58B

$1,365.04HealthcareDelayed quote: Jul 30, 2026, 11:09 AM EDT

Total return — ALNY vs MTD

growth of $100 · dividends reinvested · last 22y

ALNY +4669.1%MTD +2959.3%ALNY compounded faster

ALNY MTD

ALNY vs MTD: by the numbers

•ALNY is the larger company ($27.75B vs $27.58B market cap).
•MTD trades at the lower trailing earnings multiple (32.51 vs 68.08 P/E), one valuation lens rather than an overall verdict.
•MTD converts more revenue to profit (21.40% vs 13.46% net margin).
•ALNY grew revenue faster over the past five years (49.67% vs 4.77% CAGR).

Metrics side by side

Valuation

Metric	ALNY	MTD
P/E ratio	68.08	32.51
Forward P/E	38.45	29.75
P/S ratio	9.24	6.89
P/B ratio	36.84	N/A
PEG ratio	N/A	8.96
EV / EBITDA	48.55	23.81
FCF yield	1.62%	2.82%

Profitability

Metric	ALNY	MTD
Gross margin	80.89%	57.79%
Operating margin	17.54%	28.00%
Net margin	13.46%	21.40%
ROE	53.68%	-3677.41%
ROIC	13.74%	35.46%

Growth (annualized)

Metric	ALNY	MTD
Revenue CAGR (5Y)	49.67%	4.77%
EPS CAGR (5Y)	N/A	10.81%
FCF CAGR (5Y)	14.35%	1.98%
Total return CAGR (5Y)	9.53%	-1.69%

Frequently asked

Which has the lower trailing P/E, ALNY or MTD?: MTD has the lower trailing P/E: ALNY trades at 68.08 and MTD at 32.51. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ALNY or MTD?: Over the past five years, ALNY grew revenue faster — ALNY at a 49.67% CAGR versus MTD at 4.77%.
Is ALNY or MTD more profitable?: MTD runs the higher net margin — ALNY at 13.46% versus MTD at 21.40%.
How have ALNY and MTD total returns compared?: Over the past 10 years, ALNY delivered 15.46% and MTD delivered 12.94% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ALNY analysis Full MTD analysis Interactive comparison tool

Dig into the metrics

Alnylam Pharmaceuticals P/E ratio Mettler-Toledo International P/E ratio Alnylam Pharmaceuticals dividend yield Mettler-Toledo International dividend yield Alnylam Pharmaceuticals ROE Mettler-Toledo International ROE Alnylam Pharmaceuticals operating margin Mettler-Toledo International operating margin Alnylam Pharmaceuticals revenue growth Mettler-Toledo International revenue growth Alnylam Pharmaceuticals free cash flow Mettler-Toledo International free cash flow

Alnylam Pharmaceuticals & Mettler-Toledo International appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 30, 2026.